Natural polyphenols and their synthetic analogs as emerging anticancer agents

R. Colomer, A. Sarrats, Ruth Lupu, T. Puig

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Polyphenols are a structural class of natural and synthetic organic chemicals which contain phenol units. Numerous epidemiological, preclinical and clinical studies have strongly supported their benefical effects for human health. Polyphenols group include molecules of utterly different complexity grades, ranging from simple molecules to highly polymerized structures. They are classified into: Phenolic acids, Flavonoids, Lignans and the less common Stilbenes. This work first intends to review the current studies on classification, chemical composition and metabolism of polyphenols. Then, we have reported cancer preventive and treatment effects of polyphenols, especially focused in the green tea polyphenol (GTP) (-)-Epigallocatechin-3-gallate (EGCG). Polyphenols such as EGCG and their synthetic analogs interfere in carcinogenesis by modulating and regulating multiple signaling pathways and transcription factors, membrane-associated receptor tyrosine kinases (RTKs), fatty acid metabolism and lipid rafts or methylation together with other emerging targets such as proteasome, telomerase and cancer stem cells. Here, we have reviewed several potential molecular targets of polyphenols (mainly EGCG and EGCG analogs) and their anticancer effects in cellular and animal models of different human carcinomas and we have also listed Phases I and II clinical trials conducted to study the antitumor properties of GTPs.

Original languageEnglish (US)
Pages (from-to)147-159
Number of pages13
JournalCurrent Drug Targets
Volume18
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Polyphenols
Antineoplastic Agents
Metabolism
Organic Chemicals
Stilbenes
Lignans
Phase II Clinical Trials
Clinical Trials, Phase I
Molecules
Methylation
Neoplastic Stem Cells
Telomerase
Receptor Protein-Tyrosine Kinases
Tea
Proteasome Endopeptidase Complex
Guanosine Triphosphate
Phenol
Stem cells
Lipid Metabolism
Flavonoids

Keywords

  • Clinical trials
  • EGCG
  • FASN
  • Green tea polyphenols
  • Mouse models
  • Receptor tyrosine kinases
  • Signaling pathways
  • Targets

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Natural polyphenols and their synthetic analogs as emerging anticancer agents. / Colomer, R.; Sarrats, A.; Lupu, Ruth; Puig, T.

In: Current Drug Targets, Vol. 18, No. 2, 01.02.2017, p. 147-159.

Research output: Contribution to journalReview article

Colomer, R. ; Sarrats, A. ; Lupu, Ruth ; Puig, T. / Natural polyphenols and their synthetic analogs as emerging anticancer agents. In: Current Drug Targets. 2017 ; Vol. 18, No. 2. pp. 147-159.
@article{d6153f15241d49e88c35668ed990b4ff,
title = "Natural polyphenols and their synthetic analogs as emerging anticancer agents",
abstract = "Polyphenols are a structural class of natural and synthetic organic chemicals which contain phenol units. Numerous epidemiological, preclinical and clinical studies have strongly supported their benefical effects for human health. Polyphenols group include molecules of utterly different complexity grades, ranging from simple molecules to highly polymerized structures. They are classified into: Phenolic acids, Flavonoids, Lignans and the less common Stilbenes. This work first intends to review the current studies on classification, chemical composition and metabolism of polyphenols. Then, we have reported cancer preventive and treatment effects of polyphenols, especially focused in the green tea polyphenol (GTP) (-)-Epigallocatechin-3-gallate (EGCG). Polyphenols such as EGCG and their synthetic analogs interfere in carcinogenesis by modulating and regulating multiple signaling pathways and transcription factors, membrane-associated receptor tyrosine kinases (RTKs), fatty acid metabolism and lipid rafts or methylation together with other emerging targets such as proteasome, telomerase and cancer stem cells. Here, we have reviewed several potential molecular targets of polyphenols (mainly EGCG and EGCG analogs) and their anticancer effects in cellular and animal models of different human carcinomas and we have also listed Phases I and II clinical trials conducted to study the antitumor properties of GTPs.",
keywords = "Clinical trials, EGCG, FASN, Green tea polyphenols, Mouse models, Receptor tyrosine kinases, Signaling pathways, Targets",
author = "R. Colomer and A. Sarrats and Ruth Lupu and T. Puig",
year = "2017",
month = "2",
day = "1",
doi = "10.2174/1389450117666160112113930",
language = "English (US)",
volume = "18",
pages = "147--159",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Natural polyphenols and their synthetic analogs as emerging anticancer agents

AU - Colomer, R.

AU - Sarrats, A.

AU - Lupu, Ruth

AU - Puig, T.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Polyphenols are a structural class of natural and synthetic organic chemicals which contain phenol units. Numerous epidemiological, preclinical and clinical studies have strongly supported their benefical effects for human health. Polyphenols group include molecules of utterly different complexity grades, ranging from simple molecules to highly polymerized structures. They are classified into: Phenolic acids, Flavonoids, Lignans and the less common Stilbenes. This work first intends to review the current studies on classification, chemical composition and metabolism of polyphenols. Then, we have reported cancer preventive and treatment effects of polyphenols, especially focused in the green tea polyphenol (GTP) (-)-Epigallocatechin-3-gallate (EGCG). Polyphenols such as EGCG and their synthetic analogs interfere in carcinogenesis by modulating and regulating multiple signaling pathways and transcription factors, membrane-associated receptor tyrosine kinases (RTKs), fatty acid metabolism and lipid rafts or methylation together with other emerging targets such as proteasome, telomerase and cancer stem cells. Here, we have reviewed several potential molecular targets of polyphenols (mainly EGCG and EGCG analogs) and their anticancer effects in cellular and animal models of different human carcinomas and we have also listed Phases I and II clinical trials conducted to study the antitumor properties of GTPs.

AB - Polyphenols are a structural class of natural and synthetic organic chemicals which contain phenol units. Numerous epidemiological, preclinical and clinical studies have strongly supported their benefical effects for human health. Polyphenols group include molecules of utterly different complexity grades, ranging from simple molecules to highly polymerized structures. They are classified into: Phenolic acids, Flavonoids, Lignans and the less common Stilbenes. This work first intends to review the current studies on classification, chemical composition and metabolism of polyphenols. Then, we have reported cancer preventive and treatment effects of polyphenols, especially focused in the green tea polyphenol (GTP) (-)-Epigallocatechin-3-gallate (EGCG). Polyphenols such as EGCG and their synthetic analogs interfere in carcinogenesis by modulating and regulating multiple signaling pathways and transcription factors, membrane-associated receptor tyrosine kinases (RTKs), fatty acid metabolism and lipid rafts or methylation together with other emerging targets such as proteasome, telomerase and cancer stem cells. Here, we have reviewed several potential molecular targets of polyphenols (mainly EGCG and EGCG analogs) and their anticancer effects in cellular and animal models of different human carcinomas and we have also listed Phases I and II clinical trials conducted to study the antitumor properties of GTPs.

KW - Clinical trials

KW - EGCG

KW - FASN

KW - Green tea polyphenols

KW - Mouse models

KW - Receptor tyrosine kinases

KW - Signaling pathways

KW - Targets

UR - http://www.scopus.com/inward/record.url?scp=85011016456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011016456&partnerID=8YFLogxK

U2 - 10.2174/1389450117666160112113930

DO - 10.2174/1389450117666160112113930

M3 - Review article

VL - 18

SP - 147

EP - 159

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 2

ER -